BCL2 and breast cancer: The interaction between hyaluronan and CD44 activates the stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells [43], and it can also lead to Bcl-2 expression and chemoresistance in breast cancer cells [44].